[
  {
    "ts": "2026-02-03T03:22:00+00:00",
    "headline": "WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager",
    "summary": "WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has signed a license and research service agreement with Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) for an innovative trispecific T-cell Engager (TCE) for the treatment of B-cell mediated autoimmune diseases.",
    "url": "https://finance.yahoo.com/news/wuxi-biologics-vertex-sign-license-032200041.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "4a9df0ea-5a8e-357f-ad23-8a0f701bc17d",
      "content": {
        "id": "4a9df0ea-5a8e-357f-ad23-8a0f701bc17d",
        "contentType": "STORY",
        "title": "WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager",
        "description": "",
        "summary": "WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has signed a license and research service agreement with Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) for an innovative trispecific T-cell Engager (TCE) for the treatment of B-cell mediated autoimmune diseases.",
        "pubDate": "2026-02-03T03:22:00Z",
        "displayTime": "2026-02-03T03:22:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/wuxi-biologics-vertex-sign-license-032200041.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/wuxi-biologics-vertex-sign-license-032200041.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WXIBF"
            },
            {
              "symbol": "WXXWY"
            },
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T14:00:04+00:00",
    "headline": "Is Trending Stock Vertex Pharmaceuticals Incorporated (VRTX) a Buy Now?",
    "summary": "Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://finance.yahoo.com/news/trending-stock-vertex-pharmaceuticals-incorporated-140004344.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "ebb517f9-6f6a-3ddc-a8e1-38818ba1f521",
      "content": {
        "id": "ebb517f9-6f6a-3ddc-a8e1-38818ba1f521",
        "contentType": "STORY",
        "title": "Is Trending Stock Vertex Pharmaceuticals Incorporated (VRTX) a Buy Now?",
        "description": "",
        "summary": "Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
        "pubDate": "2026-02-03T14:00:04Z",
        "displayTime": "2026-02-03T14:00:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39",
          "originalWidth": 900,
          "originalHeight": 601,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yNgUIaj6nVgElt8k_HeWJg--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39.cf.webp",
              "width": 900,
              "height": 601,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pjdR96PEF4KSKZclyxD5FQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/trending-stock-vertex-pharmaceuticals-incorporated-140004344.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/trending-stock-vertex-pharmaceuticals-incorporated-140004344.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T13:30:04+00:00",
    "headline": "Here's How Much a $1000 Investment in Vertex Pharmaceuticals Made 10 Years Ago Would Be Worth Today",
    "summary": "Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.",
    "url": "https://finance.yahoo.com/news/heres-much-1000-investment-vertex-133004351.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "18ddac70-b2e7-33d7-acf6-18eac312c4e9",
      "content": {
        "id": "18ddac70-b2e7-33d7-acf6-18eac312c4e9",
        "contentType": "STORY",
        "title": "Here's How Much a $1000 Investment in Vertex Pharmaceuticals Made 10 Years Ago Would Be Worth Today",
        "description": "",
        "summary": "Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.",
        "pubDate": "2026-02-03T13:30:04Z",
        "displayTime": "2026-02-03T13:30:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/71afbbc0512eb3c471136d93f39079c9",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ucluz4bedY7Dxd_XS4xCHQ--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/71afbbc0512eb3c471136d93f39079c9.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Asv6z7WU__xaJFJkAJhxZQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/71afbbc0512eb3c471136d93f39079c9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-much-1000-investment-vertex-133004351.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-much-1000-investment-vertex-133004351.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T13:30:00+00:00",
    "headline": "CRSP to Report Q4 Earnings: Is a Beat in Store for the Stock?",
    "summary": "CRISPR Therapeutics heads into Q4 earnings with rising Casgevy sales, collaboration revenues from Vertex, and a history of beating estimates.",
    "url": "https://finance.yahoo.com/news/crsp-report-q4-earnings-beat-133000484.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "0c68a293-66cd-35a8-9ec6-66bfcb92f7d8",
      "content": {
        "id": "0c68a293-66cd-35a8-9ec6-66bfcb92f7d8",
        "contentType": "STORY",
        "title": "CRSP to Report Q4 Earnings: Is a Beat in Store for the Stock?",
        "description": "",
        "summary": "CRISPR Therapeutics heads into Q4 earnings with rising Casgevy sales, collaboration revenues from Vertex, and a history of beating estimates.",
        "pubDate": "2026-02-03T13:30:00Z",
        "displayTime": "2026-02-03T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/crsp-report-q4-earnings-beat-133000484.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/crsp-report-q4-earnings-beat-133000484.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "CRSP"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T19:57:29+00:00",
    "headline": "These Are The Worst 25 Stocks to Own in February",
    "summary": "Biogen stock tends to disappoint in February",
    "url": "https://finance.yahoo.com/news/worst-25-stocks-own-february-195729949.html",
    "source": "Schaeffer's Investment Research",
    "provider": "yfinance",
    "raw": {
      "id": "0379dbc9-35ff-3297-a154-6bf73409809b",
      "content": {
        "id": "0379dbc9-35ff-3297-a154-6bf73409809b",
        "contentType": "STORY",
        "title": "These Are The Worst 25 Stocks to Own in February",
        "description": "",
        "summary": "Biogen stock tends to disappoint in February",
        "pubDate": "2026-02-03T19:57:29Z",
        "displayTime": "2026-02-03T19:57:29Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/schaeffers_investment_research_24/b680502a3292b68fbff555580de6769e",
          "originalWidth": 552,
          "originalHeight": 613,
          "caption": "Worst Of February",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/C2b46_bJD9LXfp0b7GSTiw--~B/aD02MTM7dz01NTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/schaeffers_investment_research_24/b680502a3292b68fbff555580de6769e.cf.webp",
              "width": 552,
              "height": 613,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8MNZ30h5Co5iA7ExjU3qaQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/schaeffers_investment_research_24/b680502a3292b68fbff555580de6769e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Schaeffer's Investment Research",
          "url": "https://www.schaeffersresearch.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/worst-25-stocks-own-february-195729949.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/worst-25-stocks-own-february-195729949.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]